Evidence map›Paper›PMID 28941317›Full record

ReviewStem cells translational medicine2017

Concise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke.

Thorsten R Doeppner, Mathias Bähr, Dirk M Hermann, Bernd Giebel

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Stem cells translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04202770 nasuspendednot on this mapstarted 2019, after this paper: background citation

Focused Ultrasound Delivery of Exosomes for Treatment of Refractory Depression, Anxiety, and Neurodegenerative Dementias

TypeinterventionalSponsorNeurological Associates of West Los AngelesRan2019 to 2024Enrolled300ConditionsRefractory Depression, Anxiety Disorders, Neurodegenerative DiseasesArmsExosomes
NCT04250441 naunknown statusnot on this mapstarted 2018, after this paper: background citation

The Use of Transcranial Focused Ultrasound for the Treatment of Depression and Anxiety

TypeinterventionalSponsorNeurological Associates of West Los AngelesRan2018 to 2025Enrolled100ConditionsDepression, AnxietyArmsFocused Transcranial Ultrasound
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. [Research progress of different types of stem cells in treatment of ischemic stroke].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2021
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Mesenchymal stem cells for restoration of ovarian function.Clinical and experimental reproductive medicine · 2019
    Article
  19. Molecular Communication of a Dying Neuron in Stroke.International journal of molecular sciences · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Thorsten R DoeppnerDepartment of Neurology, University Medical Center Goettingen, Goettingen, Germany.ORCID 0000-0002-1222-9211
Mathias BährDepartment of Neurology, University Medical Center Goettingen, Goettingen, Germany.
Dirk M HermannDepartment of Neurology, University of Duisburg-Essen Medical School, Essen, Germany.
Bernd GiebelInstitute for Transfusion Medicine, University of Duisburg-Essen Medical School, Essen, Germany.
Nephrologisches Zentrum Goettingen · DEUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite recent advances in stroke therapy, current therapeutic concepts are still limited. Thus, additional therapeutic strategies are in order. In this sense, the transplantation of stem cells has appeared to be an attractive adjuvant tool to help boost the endogenous regenerative capacities of the brain. Although transplantation of stem cells is known to induce beneficial outcome in (preclinical) stroke research, grafted cells do not replace lost tissue directly. Rather, these transplanted cells like neural progenitor cells or mesenchymal stem cells act in an indirect manner, among which the secretion of extracellular vesicles (EVs) appears to be one key factor. Indeed, the application of EVs in preclinical stroke studies suggests a therapeutic role, which appears to be noninferior in comparison to the transplantation of stem cells themselves. In this short review, we highlight some of the recent advances in the field of EVs as a therapeutic means to counter stroke. Stem Cells Translational Medicine 2017;6:2044-2052.

Indexed as

AnimalsBrain IschemiaExtracellular VesiclesHumansMesenchymal Stem Cell TransplantationStrokeMesenchymal stem cellsNervous systemNeural differentiationStem cell transplantationStem/progenitor cell

Identifiers

PMID28941317
PMCPMC6430061
OpenAlexW2756646763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.